NCT06982989 Clinical Study on the Treatment of Pelvic Pain With Wearable Dual-band LED Device
| NCT ID | NCT06982989 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Pelvic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2023-01-01 |
| Primary Completion | 2028-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 250 participants in total. It began in 2023-01-01 with a primary completion date of 2028-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a prospective clinical trial, which intends to prospective include female pelvic pain (dysmenorrhea and chronic pelvic pain), screen suitable cases, wear dual-band LED devices in non-menstrual period, perform low-dose phototherapy on local pelvic area and acupoints, and observe the changes of pelvic pain and related serological indicators in clinical practice.
Eligibility Criteria
Inclusion Criteria: * pelvic pain Exclusion Criteria: * Irregular menstrual cycles; * Inflammatory disease; * pregnant; * Light allergy;
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06982989 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 35 Years, studying Pelvic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06982989 currently recruiting?
Yes, NCT06982989 is actively recruiting participants. Contact the research team at wzxpku2008@126.com for enrollment information.
Where is the NCT06982989 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06982989 clinical trial?
NCT06982989 is sponsored by Peking University Third Hospital. The trial plans to enroll 250 participants.